AuricX Pharmaceuticals, Inc.

AuricX Pharmaceuticals, Inc.

AuricX Pharmaceuticals is a pharmaceutical development company based in Houston.  AuricX is focused on the development and commercialization of novel anti-infectives to treat infections arising from Staphylococcus Aureus (S.aureus), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other difficult to treat pathogens.  AuricX is commercializing a repurposed clinical trial stage drug which is being developed to treat S. Aureus infections.  AuricX was formed in 2006 and is managed by Chicago-based Wildcat Venture Management.

Eric Nicolaides
448 W. 19th Street
Suite 311
Houston Tx 77008
(713) 987-7040
(281) 247-1511 fax.